Comprehensive and Safe Decongestion in Acutely Decompensated Heart Failure

Curr Heart Fail Rep. 2022 Oct;19(5):364-374. doi: 10.1007/s11897-022-00573-y. Epub 2022 Sep 1.

Abstract

Purpose of the review: Progressive intravascular, interstitial, and alveolar fluid overload underlies the transition from compensated to acutely decompensated heart failure and loop diuretics are the mainstay of treatment. Adverse effects and resistance to loop diuretics received much attention while the contribution of a depressed cardiac output to diuretic resistance was downplayed.

Recent findings: Analysis of experience with positive inotropic agents, especially dobutamine, indicates that enhancement of cardiac output is not consistently associated with increased renal blood flow. However, urinary output and renal sodium excretion increase likely due to dobutamine-mediated decrease in renal and systemic reduced activation of sympathetic nervous- and renin-angiotensin-aldosterone system. Mechanical circulatory support with left ventricular assist devices ascertained the contribution of low cardiac output to diuretic resistance and the pathogenesis and progression of kidney disease in acutely decompensated heart failure. Diuretic resistance commonly occurs in acutely decompensated heart failure. However, failure to resolve fluid overload despite high doses of loop diuretics should alert to the presence of a low cardiac output state.

Keywords: Cardiac output; Decongestion; Heart failure; Renal failure.

Publication types

  • Review

MeSH terms

  • Cardiac Output, Low / chemically induced
  • Cardiac Output, Low / complications
  • Cardiac Output, Low / drug therapy
  • Diuretics / therapeutic use
  • Dobutamine / therapeutic use
  • Heart Failure* / therapy
  • Humans
  • Sodium
  • Sodium Potassium Chloride Symporter Inhibitors / therapeutic use
  • Water-Electrolyte Imbalance* / chemically induced
  • Water-Electrolyte Imbalance* / complications
  • Water-Electrolyte Imbalance* / drug therapy

Substances

  • Diuretics
  • Sodium Potassium Chloride Symporter Inhibitors
  • Dobutamine
  • Sodium